AMMECR1LP1

Across TCGA pan-cancer cohorts, AMMECR1LP1 RNA differs between tumor and matched normal tissue in 9 of 18 cancer types tested, making tumor–normal expression one of AMMECR1LP1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where AMMECR1LP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types AMMECR1LP1 is over-expressed in tumor, although a few such as UCEC and STAD show the opposite, repressed pattern.

KICH, BRCA, and BLCA are the cancer types where AMMECR1LP1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in AMMECR1LP1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	All	+0.108	.005	5	view →
BRCA	Female	All	+0.104	<.001	4	view →
BLCA	All	III,IV	+0.132	.026	3	view →
UCEC	All	All	−0.104	.014	2	view →
LUSC	All	All	+0.078	.010	2	view →
STAD	All	II,III,IV	−0.056	.021	2	view →
THCA	All	All	−0.038	<.001	2	view →
KIRC	All	All	−0.015	.034	2	view →
HNSC	All	II,III,IV	+0.015	.028	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 9 strongest of 9 lineages.

AMMECR1LP1–KICH

Open the KICH breakdown →